Results 111 to 120 of about 738 (155)

Preservation of Platelet Function During Trimethaphan Infusion

Anesthesiology, 1990
The effect of trimethaphan (Arfonad) infusion on platelet function was prospectively evaluated in 38 (n = 38) patients (28 patients receiving trimethaphan, ten control patients) undergoing elective cardiac surgery. Any patient with a positive history for the ingestion of medication known to interfere with platelet function was excluded from the study ...
openaire   +2 more sources

The effect of trimethaphan camphorsulfonate on the human digital circulation

Clinical Pharmacology & Therapeutics, 1968
The effect of l‐norepinephrine (NE) infusion on the digital circulation was studied in four groups of patients: normotensive subjects prepared by indirect heating supplemented by (a) intravenous 2,6‐dimethyl,‐1‐diethyl piperidinium bromide (SC‐1950) or (b) by intravenous trimethaphan camphorsulfonate (TMCS); and hypertensive subjects prepared in the ...
M, Mendlowitz, N E, Naftchi, R L, Wolf, S E, Gitlow   +3 more
openaire   +2 more sources

A COMPARISON OF THE CARDIOVASCULAR EFFECTS OF SODIUM NITROPRUSSIDE AND TRIMETHAPHAN

Survey of Anesthesiology, 1977
In dogs anesthetized with pentobarbital-chloralose, cardiac output and blood flows of four regional vascular beds (superior mesenteric, left renal, left circumflex coronary and left femoral) were continuously monitered with electromagnetic flowmeters. Arterial blood pressure and heart rate were also measured.
H H, Wang, L M, Liu, R L, Katz
openaire   +2 more sources

Epidural blood flow during prostaglandin E1 or trimethaphan induced hypotension

Prostaglandins, Leukotrienes and Essential Fatty Acids, 1993
To evaluate the effect of prostaglandin E1 (PGE1) or trimethaphan (TMP) induced hypotension on epidural blood flow (EBF) during spinal surgery, EBF was measured using the heat clearance method in 30 patients who underwent postero-lateral interbody fusion under isoflurane anaesthesia. An initial dose of 0.1 microgram.kg-1.min-1 of PGE1 (15 patients), or
K, Abe, M, Kakiuchi, Y, Shimada
openaire   +3 more sources

Trimethaphan camsylate (Arfonad) and human plasma cholinesterase.

Research communications in chemical pathology and pharmacology, 1979
These results for the first time document that the brief duration of action of the ganglionic blocker, Arfonad (trimethaphan camsylate), is not due to inactivation by plasma cholinesterase. Inhibition of the enzyme in vitro by Arfonad was not altered by prior incubation of the drug in plasma at 37 degrees C for up to 16 hours nor by treatment with ...
A H, Anton, S, Czinn, J, Jazwa, L, Tam, L, Amaranath   +4 more
openaire   +1 more source

TRIMETHAPHAN

Anesthesiology, 1986
R. Hines, P. G. Barash
openaire   +1 more source

Ultra-high Dose Trimethaphan in an Infant with Severe Hypertension

Journal of Toxicology: Clinical Toxicology, 1996
Trimethaphan camsylate is a potent antihypertensive drug used to induce systemic arterial hypotension in patients undergoing major surgery and to treat severe systemic hypertension. The pharmacokinetics and pharmacodynamics of trimethaphan administered in the usual clinical dosages have been previously reported.
openaire   +2 more sources

Cerebral function during trimethaphan‐induced hypotension

Neurology, 1973
A, Magness, D, Yashon, G, Locke, W, Wiederholt, W E, Hunt   +4 more
openaire   +2 more sources

The Prognostic Value of the Trimethaphan Test

Southern Medical Journal, 1967
J F, Patterson, J W, Pearson, J S, Redding   +2 more
openaire   +2 more sources

Trimethaphan

2011
Tor Sandven, Stephen Robinson
openaire   +1 more source